HYPERSCAN: Pencil Beam Scanning Delivered at Hyper Speed

Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of seconds, benefiting from the MEVION S250's direct and efficient beam generation. The result is a fast Pencil Beam Scanning enabling robust Intensity Modulated Proton Therapy treatment delivery that is much less sensitive to patient and tumor motions, ultimately increasing the efficacy of the treatment procedure. The MEVION S250 proton therapy platform with HYPERSCAN allows you to treat with precision, accuracy and reproducibility at unparalleled speed with uncompromised beam quality. Designed for greater access by any size cancer care facility, the MEVION S250 significantly reduces the complexity, size, and cost associated with conventional proton therapy systems. The MEVION S250 is specifically engineered as upgrade-ready to continue providing the most advanced proton therapy treatment available today as well as tomorrow. Key Features : Field-Upgradeable; Streamlined Clinical Workflow with Full OIS Integration; High-Accuracy Beam Pointing with Submillimeter Position Tracking; Fast Volumetric and Layer Rescanning Capabilities; Supports Standard Gating Interface for Beam On/Off Hold

VIVIX-S 1417N is a multi-purpose portable flat panel detector for addressing busy workflow in medical facilities. Get more information on our advanced detectors and software lineup at www.vieworks.com.

Deployed on Microsoft Azure, GE Healthcare’s iCenter is a secure, cloud-based tool that provides visibility to asset service and utilization data, with 24x7 access. Watch the video below and visit Booth #7334 at RSNA 2018 to see how GE Healthcare and Microsoft are elevating radiology, together.

ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the American Society for Radiation Oncology (ASTRO) 2018 conference. The overview includes new technologies for proton therapy, MRI-guded radiation therapy, PET-guided radiotherapy, brachytherapy, SRS quality assurance, 3-D printing and mobile connectivity to the oncology information system.

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation that needs to be delivered to treat the tumor and spare surrounding healthy tissue. Javier Torres-Roca, M.D., associate professor of radiation oncology, Moffit Cancer Center, and co-founder of the genomics company Cvergenx, spoke on this topic at the ASTRO 2018 conference.

Interview with Peyman Kabolizadeh, M.D., the medical director of Beaumont Proton Therapy Center, Royal Oak, Mich. He explains how proton therapy fits into Beaumont's overall strategy of cancer treatment. He also explains Beaumont's development of proton arc therapy that is in development. He spoke on these topics at that ASTRO 2018 meeting.

Kristin Higgins, M.D., medical director of radiation oncology at the Emory Clinic at the Winship Cancer Institute, and associate professor, Department of Radiation Oncology, Emory University School of Medicine, explains how the use of a novel positron-emission tomography, computed tomography (PET-CT) system combined with a linac in a single gantry might offer a new approach to real-time adaptive therapy. She spoke to ITN at the 2018 ASTRO conference.

VIVIX-S 1417N is a multi-purpose portable flat panel detector for addressing busy workflow in medical facilities. Get more information on our advanced detectors and software lineup at www.vieworks.com.

Deployed on Microsoft Azure, GE Healthcare’s iCenter is a secure, cloud-based tool that provides visibility to asset service and utilization data, with 24x7 access. Watch the video below and visit Booth #7334 at RSNA 2018 to see how GE Healthcare and Microsoft are elevating radiology, together.

Organizations who are embarking on an enterprise imaging journey share many of the same questions and concerns regarding how to best optimize workflow across providers, departments and facilities; which technologies will provide the best fit for achieving the future vision; and how to maximize value and accelerate return on investment by driving adoption and improving satisfaction among providers and healthcare consumers (patients).

We, Paragon Consulting Partners LLC (PCP Imaging), are a team of passionate healthcare professionals that bring over 100 years of collective clinical, technical and business leadership experience within the healthcare IT and imaging informatics industries. In this video we address the key challenges and considerations faced by organizations undertaking an Enterprise Imaging journey, and how a trusted partner can contribute valuable expertise and guidance that enable healthcare organizations and vendors of any size to successfully tackle even their most challenging enterprise imaging initiatives. For more information, visit pcpimaging.com.

Fujifilm details its latest innovations in women's health including its ASPIRE Cristalle mammography system with digital breast tomosynthesis software option and its Synapse 5 PACS and VNA, enabling secure, easy-to-manage storage and access to the complete patient imaging record throughout the healthcare enterprise.

This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging. It combines ease-of-use, such as a narrow bezel design to help your eyes swiftly move from one monitor to another, with new functions to help you focus on your work and maintain high performance.

ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Society of North America (RSNA) 2017 annual meeting. AI was by far the hottest topic in sessions and on the expo floor at RSNA 2017. Here are links to related deep learning, machine learning coverage:

Contributing Editor Greg Freiherr offers an overview of computed tomography (CT) advances at the Radiological Society of North America (RSNA) 2015. The video includes Freiherr during his booth tours with some of the key vendors who were featuring new technology.

ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the American Society for Radiation Oncology (ASTRO) 2018 conference. The overview includes new technologies for proton therapy, MRI-guded radiation therapy, PET-guided radiotherapy, brachytherapy, SRS quality assurance, 3-D printing and mobile connectivity to the oncology information system.

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation that needs to be delivered to treat the tumor and spare surrounding healthy tissue. Javier Torres-Roca, M.D., associate professor of radiation oncology, Moffit Cancer Center, and co-founder of the genomics company Cvergenx, spoke on this topic at the ASTRO 2018 conference.

Interview with Peyman Kabolizadeh, M.D., the medical director of Beaumont Proton Therapy Center, Royal Oak, Mich. He explains how proton therapy fits into Beaumont's overall strategy of cancer treatment. He also explains Beaumont's development of proton arc therapy that is in development. He spoke on these topics at that ASTRO 2018 meeting.

Kristin Higgins, M.D., medical director of radiation oncology at the Emory Clinic at the Winship Cancer Institute, and associate professor, Department of Radiation Oncology, Emory University School of Medicine, explains how the use of a novel positron-emission tomography, computed tomography (PET-CT) system combined with a linac in a single gantry might offer a new approach to real-time adaptive therapy. She spoke to ITN at the 2018 ASTRO conference.

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology (ASTRO), gives an update on where things are at for radiotherapy reimbursement, CMS conversion factors and MACRA. She spoke on this topic at the 2018 ASTRO conference.

ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the American Society for Radiation Oncology (ASTRO) 2018 conference. The overview includes new technologies for proton therapy, MRI-guded radiation therapy, PET-guided radiotherapy, brachytherapy, SRS quality assurance, 3-D printing and mobile connectivity to the oncology information system.

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation that needs to be delivered to treat the tumor and spare surrounding healthy tissue. Javier Torres-Roca, M.D., associate professor of radiation oncology, Moffit Cancer Center, and co-founder of the genomics company Cvergenx, spoke on this topic at the ASTRO 2018 conference.

Interview with Peyman Kabolizadeh, M.D., the medical director of Beaumont Proton Therapy Center, Royal Oak, Mich. He explains how proton therapy fits into Beaumont's overall strategy of cancer treatment. He also explains Beaumont's development of proton arc therapy that is in development. He spoke on these topics at that ASTRO 2018 meeting.

Kristin Higgins, M.D., medical director of radiation oncology at the Emory Clinic at the Winship Cancer Institute, and associate professor, Department of Radiation Oncology, Emory University School of Medicine, explains how the use of a novel positron-emission tomography, computed tomography (PET-CT) system combined with a linac in a single gantry might offer a new approach to real-time adaptive therapy. She spoke to ITN at the 2018 ASTRO conference.

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology (ASTRO), gives an update on where things are at for radiotherapy reimbursement, CMS conversion factors and MACRA. She spoke on this topic at the 2018 ASTRO conference.

VIVIX-S 1417N is a multi-purpose portable flat panel detector for addressing busy workflow in medical facilities. Get more information on our advanced detectors and software lineup at www.vieworks.com.

A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Group and head of the Duke medical physics graduate program. He spoke on this topic at the American Association of Physicists in Medicine (AAPM) 2018 meeting.

Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott White Heart Hospital, Dallas, explains the utility of magnetic resonance imaging (MRI) in cardiology and the implementation of the cardiac MRI program at his hospital.

A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada. He spoke on this topic in sessions at the American Association of Physicists in Medicine (AAPM) 2018 meeting. He explains radiomics and how it can be used in both medical imaging and radiation therapy.

Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and president-elect of the American Society of Nuclear Cardiology (ASNC), explained advances in PET and SPECT imaging and the learning curve involved in reading scans from the new CZT SPECT cameras. Watch the VIDEO: Trends in Nuclear Cardiology Imaging, an iknterview with David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida. Read the related article "Advances in Cardiac Nuclear Imaging."

Kim A. Williams, Sr., M.D., chief of cardiology at Rush University Medical Center, Chicago and former president of both the American College of Cardiology (ACC) and the American Society of Nuclear Cardiology (ASNC), explains the impact of healthcare reform on cardiology and specifically on nuclear perfusion imaging.

David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty.

American Association of Physicists in Medicine (AAPM) President John Boone, Ph.D., discusses the impact of imaging in medical physics, as well as key topics addressed at this year’s meeting, with Imaging Technology News Editorial Director Melinda Taschetta-Millane.

Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of seconds, benefiting from the MEVION S250's direct and efficient beam generation. The result is a fast Pencil Beam Scanning enabling robust Intensity Modulated Proton Therapy treatment delivery that is much less sensitive to patient and tumor motions, ultimately increasing the efficacy of the treatment procedure. The MEVION S250 proton therapy platform with HYPERSCAN allows you to treat with precision, accuracy and reproducibility at unparalleled speed with uncompromised beam quality. Designed for greater access by any size cancer care facility, the MEVION S250 significantly reduces the complexity, size, and cost associated with conventional proton therapy systems. The MEVION S250 is specifically engineered as upgrade-ready to continue providing the most advanced proton therapy treatment available today as well as tomorrow. Key Features : Field-Upgradeable; Streamlined Clinical Workflow with Full OIS Integration; High-Accuracy Beam Pointing with Submillimeter Position Tracking; Fast Volumetric and Layer Rescanning Capabilities; Supports Standard Gating Interface for Beam On/Off Hold

DAIC Editor Dave Fornell shares his choices for the most innovative new technologies in nuclear imaging that were on display at the 2014 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

Deployed on Microsoft Azure, GE Healthcare’s iCenter is a secure, cloud-based tool that provides visibility to asset service and utilization data, with 24x7 access. Watch the video below and visit Booth #7334 at RSNA 2018 to see how GE Healthcare and Microsoft are elevating radiology, together.

ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the American Society for Radiation Oncology (ASTRO) 2018 conference. The overview includes new technologies for proton therapy, MRI-guded radiation therapy, PET-guided radiotherapy, brachytherapy, SRS quality assurance, 3-D printing and mobile connectivity to the oncology information system.

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation that needs to be delivered to treat the tumor and spare surrounding healthy tissue. Javier Torres-Roca, M.D., associate professor of radiation oncology, Moffit Cancer Center, and co-founder of the genomics company Cvergenx, spoke on this topic at the ASTRO 2018 conference.

A discussion with Kevin Moore, Ph.D., DABR, deputy director of medical physics and associate professor, University of California San Diego, about his daily clinical use of an artificial intelligence treatment planning software. He spoke on this at the American Association of Physicists in Medicine (AAPM) 2018 meeting.

Radiological Society of North America (RSNA) President Vijay Rao, M.D., the David C. Levin professor and chair of radiology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, spoke to ITN at the 2018 AAPM meeting. She said artificial intelligence is by far the most impactful new technology in radiology and it will be by far be one of the hottest topics at the 2018 RSNA annual meeting.

A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada. He spoke on this topic in sessions at the American Association of Physicists in Medicine (AAPM) 2018 meeting. He explains radiomics and how it can be used in both medical imaging and radiation therapy.

Sheila Sferrella, president of Regents Health Resources and Bill Finerfrock, president of Capitol Associates, discuss the latest updates to clinical decision support (CDS)/appropriate use criteria (AUC) requirements from the Centers for Medicare and Medicaid Services (CMS). Sferrella is the chair and Finerfrock is a member of the AHRA Regulatory Affairs Committee.

ITN Editorial Director Melinda Taschetta-Millane speaks to DenseBreast-info Executive Director JoAnn Pushkin as the website celebrates three years as an information resource on breast density for patients and providers. Pushkin also discusses the latest developments in breast density notification and screening guidelines.

Fujifilm details its latest innovations in women's health including its ASPIRE Cristalle mammography system with digital breast tomosynthesis software option and its Synapse 5 PACS and VNA, enabling secure, easy-to-manage storage and access to the complete patient imaging record throughout the healthcare enterprise.